Gene expression signature of TP53 but not its mutation status predicts response to sequential paclitaxel and 5-FU/epirubicin/cyclophosphamide in human breast cancer
Keyword(s):
2011 ◽
Vol 17
(7)
◽
pp. 2024-2034
◽
Keyword(s):
2005 ◽
Vol 102
(49)
◽
pp. 17882-17882
◽
Keyword(s):
2014 ◽
Vol 32
(15_suppl)
◽
pp. 11069-11069
2005 ◽
Vol 102
(38)
◽
pp. 13550-13555
◽
Keyword(s):
Keyword(s):
1986 ◽
Vol 261
(12)
◽
pp. 5562-5567
Keyword(s):
1997 ◽
Vol 60
(5-6)
◽
pp. 269-276
◽
Keyword(s):